Objective: To explore the role of the Act1/NF-κB signaling pathway in the development of hypercoagulation states in patients with rheumatoid arthritis (RA).
Introduction
Rheumatoid Arthritis (RA) is a chronic, systemic, autoimmune disease, characterized by joint synovitis, with inflammatory cell infiltrates and bone and cartilage matrix destruction caused by activated synovial fibroblasts [1, 2] . In China, the incidence of RA is about 0.33%; the incidence for females is three times that of males. The pathogenesis of RA is linked to immune dysfunction and an imbalance of T helper cells is associated with disease progression [3] . Effector T cells are responsible for promoting the production of autoantibodies and they release a variety of pro-inflammatory cytokines, initiating and perpetuating chronic inflammation in RA [4, 5] .
Nuclear factor kappa B (NF-κB) is an essential transcription factor, which regulates the expression of inflammatory cytokines such as IL-17 and IL-6 [6] . NF-κB plays a key role in the pathogenesis of RA; it has been shown to regulate the inflammatory response, promote synovial cell hyperplasia and reconstruction of the joint architecture. Recent studies have shown that the development of RA is accompanied by a disturbance of the coagulation fibrinolysis system with clinical manifestations that include high blood coagulation [7] [8] [9] . Additionally, platelet activating factor (PAF), a potent phospholipid activator, was shown to be an important mediator of leukocyte function and inflammation [10, 11] . PAF plays a key role in the infiltration of inflammatory cells to the joints, thus, PAF and a high coagulation state, are closely related to the processes of synovitis, tissue destruction, angiogenesis, and induced platelet aggregation [12] .
The present study explores the role of a high coagulation state in the pathogenesis of RA and its regulation by the NF-κB pathway.
Materials and Methods

Materials
Patients: The study cohort comprised 30 RA inpatients at the department of rheumatology of the First Affiliated Hospital of Anhui University of Traditional Chinese Medicinea and was carried out from January 2014 to December 2014. Patients had active disease, DAS28 score > 2.6, and were defined using the RA classification standards proposed by the 2010 American Rheumatism Association joint European League against rheumatism [13] . There were 20 females and 10 males, aged 28-70 years (mean 50.80 ± 11.01 years). The duration of illness was 0.5-20 years (mean 9.20 ± 5.75 years). The control group comprised 20 healthy individuals, consisting of 15 females and 5 males, aged 20-58 years (mean 38.63 ± 9.13 years).
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Chicago, IL, USA). Measurement data are the mean ± standard deviation (SD) of normally distributed data. The independent-samples t-test was used to compare measurement data between groups. The rank and inspection test was used for non-normally distributed data. Multiple regression analysis was carried out for relevant data. P < 0.05 was considered significant.
Results
Coagulation index levels in RA patients
Firstly, we analyzed coagulation parameters and found that, compared with the control group, D-D, FBG and PLT were significantly increased in the RA patients' peripheral blood (P < 0.01). Abnormal cases were 26, 17, and 12, respectively, accounting for 86.67%, 56.67%, and 40%. APTT and TT were shortened (P < 0.05); abnormal cases were 5 and 1, respectively, accounting for 16.67% and 3.33%. PT was not significantly different between the two groups (P > 0.05); however, a difference was apparent; abnormal cases were 2, accounting for 6.67% (Table 2, Figure 1 ).
Analysis of cytokines, NF-κB and PAF/PAF-AH in RA patient serum
Analysis of RA patient serum showed that IL-4, IL-10 and PAF-AH levels were significantly decreased, compared with healthy controls (P < 0.05). Conversely, IL-6, IL-17, Act1, p50, p65, IκBα and PAF were significantly increased (P < 0.05; Table 3 ).
Analysis of signaling molecule mRNA in RA patients
Compared with the healthy control group, mRNA encoding Act1, p65, p50, IκBα and Iκκα levels were significantly increased in RA patient samples (P < 0.05; Figure 1 ).
Analysis of p50, p65 and IκBα protein levels in RA patients
Compared with the healthy control group, p50, p65 and IκBα protein levels were significantly increased in RA patient samples (P < 0.05; Figure 2 ).
Correlations between coagulation indicators, cytokines, and NF-κB
Multiple regression analysis showed that, in patients with RA, D-D positively correlated with ESR, IL-17, IL-6 and p50. FBG positively correlated with ESR and IL-6; PLT positively correlated with DAS28, CCP, CRP, IL-17 and p50, and negatively with IL-4; PT positively correlated with IκBα; PAF positively correlated with RF, They were recruited from the Anhui Province hospital medical center, and were not suffering from any known diseases. The distribution of age and sex were comparable between the two groups and there was no statistically significant difference (P > 0.05). The study protocol was approved by the ethics committee of the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine (Anhui Hefei, China; 2012AH-020-01). The study participants all provided informed consent.
Methods
Determination of immunological disease correlates in peripheral blood: IL-10, IL-6, IL-4, IL-17, Act1, p50, p65, IκBa, PAF and PAF-AH levels were detected with enzyme-linked immunosorbent assays (ELISA; R&D Systems, USA). Five ml of venous blood was taken from each patient, during the morning following fasting, and centrifuged for 15 min at 3000 rpm. Supernatants were stored at -80°C.
Determination of biochemical disease correlates in peripheral blood: Platelets (PLT) were detected using a Sysmex XT-2000i automated hematology analyzer (Sysmex, Hyogo, Japan). D-dimer (D-D), thrombin time (TT), prothrombin time (PT), partial thromboplastin time (APTT) and fibrinogen (FBG) levels were detected using a Sysmex CA-1500 automatic coagulation analyzer. Erythrocyte sedimentation rate (ESR) was detected using the Westergren method. C-reactive protein (Hs-CRP) and rheumatoid factor (RF) were detected using a Hitachi 7060 automatic biochemical analyzer (Hitachi Chemical Co, Tokyo, Japan). mRNA isolation and PCR: mRNA encoding Act1, p65, p50, IκBα and IKKα were detected using semi-quantitative PCR. The primer sequences are shown in table 1. Total RNA was extracted from patients' blood using TRIzol (ThermoFisher Scientific) and the instructions of the primer manufacturer (Invitrogen). Reverse transcription was performed using a reverse transcription kit (Thermo Scientific). PCR reaction conditions used were as follows: 5 min of initial denaturation at 95°C; 35 cycle programmed with 30 s of denaturation at 95°C, 30 s of annealing at 55°C and 50 s of extension at 72°C; and finally 10 min extension at 72°C. PCR products were detected by electrophoresis on 1.5% agarose gels, which included 0.1 µg/mL ethidium bromide. The gels were photographed and analyzed using Image Pro Plus software to calculate the integrated optical density where the integrated optical density of mRNA/β-actin was the relative amount of mRNA.
Protein isolation and western blotting: Total protein was extracted from peripheral blood using a preparation of modified radioimmunoprecipitation buffer (Blue Skies Technology) and quantified using a Coomassie brilliant blue protein quantitative kit (Abcam). p50, p65 and IκBa protein levels were detected by western blot. The integral absorbance value of the bands was detected with BandScan software, and the ratios, p50/β-actin, p65/β-actin and IκBa/ β-actin determined the relative amount of p50, p65 and IκBa protein expression level, respectively.
Statistical analyses
Statistical analyses were carried out using SPSS v17.0 (IBM,
Gene
Primer sequence Amplification length (bp) β-actin F: 5ʹ-GTGGACATCCGCAAAGAC-3ʹ 302 R: 5ʹ-AAAGGGTGTAACGCAACTAA-3ʹ 
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CRP, CCP, IL-17, IL-6, p65 and p50, and negatively with IL-4; PAF-AH negatively correlated with p50 and positively with IL-4 (P < 0.05, P < 0.05; Table 4 ).
Discussion
RA is a chronic autoimmune inflammatory disease; however its precise etiology and pathogenesis are unclear. Basic pathological changes include synovitis, joint synovial hyperplasia and pannus formation [14, 15] . The incidence of RA is 0.5%-1.0%, with a high disability rate for patients with RA [16] . Existing studies have shown that the coagulation fibrinolytic indexes, FBG and D-D, were significantly higher in RA patients than in healthy controls [17, 18] . FBG is synthesized by the liver and forms an essential component of blood clots. D-D is a product of cross linked fibrin degradation. It serves as a marker of high coagulation and fibrinolytic hyper function, with alterations in D-D concentration indicating dysfunction of the coagulation fibrinolytic system [19] . PLT are another essential element in blood coagulation, inflammation and thrombosis [20] . Our results suggested that alterations in the blood coagulation fibrinolytic system in patients with RA had occurred. Therefore, a high coagulation state may be a major clinical manifestation of RA. At present, the high coagulation state in RA patients is poorly understood in theory and clinical practice. To gain insight into the relationship between the level of coagulation and disease state, we performed statistical analyses on blood coagulation fibrinolytic abnormalities in 30 patients with RA. Our results showed that D-D, FBG and PLT were significantly increased in RA patients compared with healthy controls. Furthermore, APTT and TT were decreased, whereas PT showed no significant changes, despite showing some abnormalities. The results of this study are consistent with previous studies [18, 21] thus suggesting that blood coagulation fibrinolytic system abnormalities may be of importance to the disease state in RA.
The abnormal change of coagulation fibrinolytic indexes in patients with RA was closely related to immune inflammation indexes. However, coagulation fibrinolytic system disorders were closely related to an imbalance of pro-and anti-inflammatory cytokines. Our results showed that IL-10 was negatively correlated with D-D [22] . IL-4 has been shown to produce antiplatelet antibodies, which led to a decrease in platelet number [23] . Additionally, IL-4 can co-operate with IL-10 [24] . IL-6 has been shown to up-regulate fibrinogen production to promote high blood coagulation, and is correlated with the degree of vascular inflammation [25] . IL-17 is a proinflammatory cytokine capable of stimulating fibroblasts to secrete IL-6 and other inflammatory factors. IL-17 signaling can lead to the activation of IKKα by Actl, which leads to the phosphorylation of IκBα and its eventual degradation. Degradation of IκBα enables the nuclear translocation of NFκB, in which it functions as a transcription factor that promotes the transcription of pro-inflammatory-related genes. Chang et al. [26] showed that Actl-mediated activation of NF-κB was dependent on IL-17, constituting an important signal transduction regulator. IL-17 is secreted extracellularly, activating NF-κB, and leading to increased secretion of IL-6 [27] . IL-6, in turn, induces neutrophils and other granulocytes to produce PAF, potentiating the inflammatory reaction, and stimulating synovial cell proliferation [12] and platelet aggregation [28] , thus, contributing to the occurrence of high coagulation states in RA patients. PAF-AH is capable of inactivating PAF, thus, the dynamic balance between PAF and PAF-AH plays an important role in maintaining the normal activity of PAF. As a result, the change in PAF-AH could also lead to a high blood coagulation state. Our study found that IL-4, IL-10 and PAF-AH levels were significantly decreased in RA patients; however, IL-6, IL-17, PAF, Act1, p50, p65, IκBα and IKKα were significantly increased. Collectively, this suggests that abnormal activation of NF-κB occurs, with a resulting imbalance of cytokines and abnormal changes in blood coagulation fibrinolysis indicators in patients with RA.
Additionally, the results demonstrate that D-D positively correlated with ESR, IL-17, IL-6 and p50. FBG positively correlated with ESR and IL-6, whereas PLT positively correlated with DAS28, CCP, CRP, IL-17 and p50, and negatively with IL-4. Furthermore, PT positively correlated with IκBa; PAF positively correlated with RF, CRP, CCP, IL-17, IL-6, p65 and p50, and negatively with IL-4; PAF-AH was negatively correlated with p50, and positively with IL-4 (Table 4) . Collectively, these results suggest that the changes in coagulation indexes were closely related to clinical symptoms and inflammatory factors, activity indexes and abnormal activation of NF-κB in RA patients.
In conclusion, the occurrence of high coagulation state in RA patients might be a result of abnormal activation of NF-κB, thereby up-regulating the expression of D-D, FBG, PLT and PAF, and downregulating the expression of APTT, PT, TT and PAF-AH. It is also possible that the occurrence of a high blood coagulation state may be related to increased IL-6 and IL-17, and decreased IL-4 and IL-10. However, the mechanism of developing into a high coagulation state requires further study to determine possible targets for therapeutic intervention. Table 4 : Correlations between coagulation indicators, cytokines, and NF-κB (r).
